IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content

Vaccine

Volumn 27, Issue 47, 2009, Pages 6530-6536

  Hendrikx, Lotte H ^a,b   Berbers, Guy A M ^a   Veenhoven, Reinier H ^b   Sanders, Elisabeth A M ^c   Buisman, Anne Marie ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Infection and Immunology   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibodies; Booster response; Pertussis vaccines

Indexed keywords

ACV SB; ANTIBODY; ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FIMBRIA PROTEIN; HAEMOPHILUS INFLUENZAE VACCINE; HEMAGGLUTININ; IMMUNOGLOBULIN G; INFANRIX IPV HIB; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; TRIAXIS; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BINDING AFFINITY; CHILD; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; WHOLE CELL;

ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; NETHERLANDS; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 70449115578     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.052     Document Type: Article

References (42)

1. de Melker H.E., Conyn-van Spaendonck M.A., Rumke H.C., van Wijngaarden J.K., Mooi F.R., and Schellekens J.F. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis 3 2 (1997) 175-178
2. Preziosi M.P., and Halloran M.E. Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. Clin Infect Dis 37 6 (2003) 772-779
3. Pebody R.G., Gay N.J., Giammanco A., Baron S., Schellekens J., Tischer A., et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 133 1 (2005) 159-171
4. Celentano L.P., Massari M., Paramatti D., Salmaso S., and Tozzi A.E. Resurgence of pertussis in Europe. Pediatr Infect Dis J 24 9 (2005) 761-765
5. de Melker H.E., Schellekens J.F., Neppelenbroek S.E., Mooi F.R., Rumke H.C., and Conyn-van Spaendonck M.A. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 6 4 (2000) 348-357
6. Broutin H., Guegan J.F., Elguero E., Simondon F., and Cazelles B. Large-scale comparative analysis of pertussis population dynamics: periodicity, synchrony, and impact of vaccination. Am J Epidemiol 161 12 (2005) 1159-1167
7. Berbers G.A., de Greeff S.C., and Mooi F.R. Improving pertussis vaccination. Hum Vaccin 5 6 (2009)
8. Crowcroft N.S., and Pebody R.G. Recent developments in pertussis. Lancet 367 9526 (2006) 1926-1936
9. Berbers GAM, Lafeber AB, Labadie J, Vermeer-de Bondt PE, Bolscher DJA, Plantinga AD. A randomised controlled study with whole-cell or acellular pertussis vaccines in combination with regular DT-IPV vaccine and a new poliomyelitis (IPV-Vero) component in children 4 years of age in the Netherlands. Bilthoven: RIVM; 1999. Report No.: RIVM report 105000.001.
10. de Greeff S.C., Mooi F.R., Schellekens J.F., and de Melker H.E. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J 27 3 (2008) 218-223
11. Schellekens J., von Konig C.H., and Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J 24 Suppl 5 (2005) S19-24
12. Wirsing von Konig C.H., Postels-Multani S., Bock H.L., and Schmitt H.J. Pertussis in adults: frequency of transmission after household exposure. Lancet 346 8986 (1995) 1326-1329
13. van Gageldonk P.G., van Schaijk F.G., van der Klis F.R., and Berbers GA. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J Immunol Methods 335 1-2 (2008) 79-89
14. Meade B.D., Deforest A., Edwards K.M., Romani T.A., Lynn F., O'Brien C.H., et al. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 96 3 Pt 2 (1995) 570-575
15. Prince H.E., Lape-Nixon M., and Matud J. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies. Clin Vaccine Immunol 13 2 (2006) 266-270
16. Reder S., Riffelmann M., Becker C., and Wirsing von Konig C.H. Measuring immunoglobulin g antibodies to tetanus toxin, diphtheria toxin, and pertussis toxin with single-antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay. Clin Vaccine Immunol 15 5 (2008) 744-749
17. Long S.S., Welkon C.J., and Clark J.L. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 161 3 (1990) 480-486
18. Huang L.M., Lee C.Y., Lin T.Y., Chen J.M., Lee P.I., and Hsu C.Y. Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age. Vaccine 14 9 (1996) 916-922
19. Guiso N., Njamkepo E., Vie le Sage F., Zepp F., Meyer C.U., Abitbol V., et al. Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Vaccine 25 8 (2007) 1390-1397
20. Versteegh F.G., Mertens P.L., de Melker H.E., Roord J.J., Schellekens J.F., and Teunis P.F. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect 133 4 (2005) 737-748
21. Giuliano M., Mastrantonio P., Giammanco A., Piscitelli A., Salmaso S., and Wassilak S.G. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr 132 6 (1998) 983-988
22. Pichichero M.E., Rennels M.B., Edwards K.M., Blatter M.M., Marshall G.S., Bologa M., et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA 293 24 (2005) 3003-3011
23. Goldblatt D., Richmond P., Millard E., Thornton C., and Miller E. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J Infect Dis 180 2 (1999) 538-541
24. Baughman A.L., Bisgard K.M., Edwards K.M., Guris D., Decker M.D., Holland K., et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 11 6 (2004) 1045-1053
25. Vincent J.M., Cherry J.D., Nauschuetz W.F., Lipton A., Ono C.M., Costello C.N., et al. Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation. Clin Infect Dis 30 3 (2000) 534-539
26. Isacson J., Trollfors B., Taranger J., and Lagergard T. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr Infect Dis J 14 6 (1995) 517-521
27. Hallander H.O., Gustafsson L., Ljungman M., and Storsaeter J. Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose. Vaccine 23 46-47 (2005) 5359-5364
28. Nolan T., Ruff T.A., Lambert S.B., Buttery J., O'Grady K.-A., Streeton C., et al. Booster vaccination of toddlers with reduced antigen content diphtheria-tetanus-acellular pertussis vaccine. Vaccine 27 18 (2009) 2410-2413
29. Gustafsson L., Hallander H.O., Olin P., Reizenstein E., and Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334 6 (1996) 349-355
30. Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A.E., Anemona A., et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 334 6 (1996) 341-348
31. Podda A., Bona G., Canciani G., Pistilli A.M., Contu B., Furlan R., et al. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine. J Pediatr 127 2 (1995) 238-243
32. Knuf M., Habermehl P., Faber J., Bock H.L., Sanger R., Bogaerts H., et al. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life. Vaccine 24 27-28 (2006) 5627-5636
33. Thalen M., van der Ark A., van den Ijssel J., van Straaten I., Jansen D., Beuvery C., et al. Improving the cellular pertussis vaccine: increased potency and consistency. Vaccine 26 5 (2008) 653-663
34. Lanzavecchia A., and Sallusto F. Human B cell memory. Curr Opin Immunol 21 3 (2009) 298-304 Epub 2009 Jun 6
35. Plotkin S.A., and Orenstein W.A. Vaccines. third ed. (2008), W.B. Saunders Company, Pennsylvania, USA
36. Storsaeter J., Hallander H.O., Gustafsson L., and Olin P. Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 21 25-26 (2003) 3542-3549
37. Taranger J., Trollfors B., Lagergard T., Sundh V., Bryla D.A., Schneerson R., et al. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis 181 3 (2000) 1010-1013
38. Hellwig S.M., Rodriguez M.E., Berbers G.A., van de Winkel J.G., and Mooi F.R. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J Infect Dis 188 5 (2003) 738-742
39. Cherry J.D., Gornbein J., Heininger U., and Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16 20 (1998) 1901-1906
40. Plotkin S.A. Vaccines: Correlates of Vaccine-Induced Immunity. Clin Infect Dis 47 3 (2008 Aug 1) 401-409 Review
41. Ausiello C.M., Lande R., Urbani F., la Sala A., Stefanelli P., Salmaso S., et al. Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect Immun 67 8 (1999) 4064-4071
42. Cassone A., Mastrantonio P., and Ausiello C.M. Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients?. J Infect Dis 182 5 (2000) 1575-1577